Use of CRF antagonists and renin-angiotensin system inhibitors
US6387894B1 · kind B1 · utility
85Cited by
0References
26Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 2, 2000 |
| Grant date | May 14, 2002 |
| Priority date | — |
| Expiry date | Jul 28, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compositions and methods of achieving a therapeutic effect including, but not limited to, the treatment of congestive heart failure or hypertension in an animal, preferably a mammal including a human subject or a companion animal, using a corticotropin releasing factor (CRF) antagonist and a renin-angiotensin system (RAS) inhibitor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.